Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02910492 · ClinicalTrials.gov registry record · NA
Study of a Novel Laser for Skin Rejuvenation
A NA study of Rejuvenation, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT02910492 is a NA study of Rejuvenation that has completed, run by Cutera. The registered enrollment target is 10 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT02910492, a NA study of Rejuvenation, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
Single-center study to evaluate the safety and efficacy of an investigational version of the enlighten™ 670nm laser for photo-rejuvenation.
Conditions Studied
Interventions
- DEVICE enLighten Laser
Study Locations (2)
California
- Cutera Research Clinic - Brisbane
Connecticut
- Connecticut Skin Institute - Stamford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02910492
The ClinicalTrials.gov registry entry for NCT02910492 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cutera, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rejuvenation appearing as the primary indexed condition, and to 1 intervention - of which enLighten Laser is the first listed.
NCT02910492 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Connecticut.
Frequently Asked Questions
What is clinical trial NCT02910492 about?
NCT02910492 is a clinical study titled "Study of a Novel Laser for Skin Rejuvenation". Single-center study to evaluate the safety and efficacy of an investigational version of the enlighten™ 670nm laser for photo-rejuvenation.
What is the current status of trial NCT02910492?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2016-09. Estimated completion is 2017-03.
What conditions does trial NCT02910492 study?
This clinical trial studies the following conditions: Rejuvenation.
What interventions are being tested in trial NCT02910492?
The interventions under investigation include: enLighten Laser (DEVICE).
Who is sponsoring clinical trial NCT02910492?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02910492 being conducted?
This trial has 2 study locations across California, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rejuvenation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.